Sickle cell disease: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  NCT07224360· CSL Behring· Source

• A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  NCT06546670· Novartis Pharmaceuticals· Source

• The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  NCT06975865· Sanofi· Source

• Gene Editing For Sickle Cell Disease

  NCT06506461· St. Jude Children's Research Hospital· Source

• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  NCT06439082· Novartis Pharmaceuticals· Source

• Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

  NCT03814746· Novartis Pharmaceuticals· Source

• Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· CSL Behring· Source

• Cooperative Assessment of Late Effects for SCD Curative Therapies

  NCT05153967· Vanderbilt University Medical Center· Source

• Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire

  NCT07488520· Swiss Tropical & Public Health Institute· Source

• A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants

  NCT06813924· Novo Nordisk A/S· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Gene Expression Profiling 2
• Proteomics 1
• Flow Cytometry 1
• Cohort Studies 3

See which targets of this disease your abstract mentions, and go to the people working on them.